MCM
AURA icon

MAI Capital Management’s Aura Biosciences AURA Stock Holding History

MAI Capital Management’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$108 Buy
+16
New +$92 ﹤0.01% 4748

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

MAI Capital Management's AURA Position: Q1 2026 in Review

MAI Capital Management opened a new position in Aura Biosciences (AURA) in Q1 2026: 16 shares worth $108. The stake represents ﹤0.01% of the portfolio and ranks #4748 among its holdings.

126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • MAI Capital Management held 16 shares of Aura Biosciences worth $108 as of Q1 2026.
  • Aura Biosciences was a new MAI Capital Management position in Q1 2026.
  • Aura Biosciences made up ﹤0.01% of MAI Capital Management's portfolio in Q1 2026, its #4748 holding.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.